Precision medicine through polymathic AI
CoSyne Therapeutics has raised $7.8M in total funding. The most recent round was Pre-Seed. The last funding was announced in May 2022.
CoSyne Therapeutics's investors include BACKED VC, Meltwind Advisory, Amino Collective.
CoSyne Therapeutics is headquartered in London, United Kingdom.
Precision medicine through polymathic AI
CoSyne Therapeutics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CoSyne Therapeutics — Funding & Investors." VCBacked, May 20, 2022, https://www.vcbacked.co/company/cosyne-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). CoSyne Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cosyne-therapeutics
{{cite web |title=CoSyne Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cosyne-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated